|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | P300 acetyltransferase activity differentially regulates the lo- calization and activity of the FoxO homologues in skeletal muscle 显示文摘 | SENF S M SANDESARA P B REED S A | 2011 | Cell Physiology2011，300，6： | 1 |
| 2 | A forward genetic strategy reveals destabilizing mutations in the Ebola virus glycoprotein that alter its protease dependence during cell entry 显示文摘 | Wong A C Sandesara R G Mulherkar N | 2010 | J Virol2010，84，1： | 1 |
| 3 | Cardiac rehabil- itation and risk reduction:Time to 'Rebrand and Reinvigo- rate'显示文摘 | Sandesara PB Lambert CT Gordon NF | 2015 | J Am Coll Cardiol2015，65，4： | 1 |
| 4 | A Randomized,Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery:The FISH Trial显示文摘 | Sandesara CM Chung MK Van Wagoner DR | 2012 | J Am Heart Assoc2012，1，00： | 1 |
| 5 | Inhibition of foxo transcriptional activity prevents muscle fiber at- rophy during cachexia and induces hypertrophy显示文摘 | Reed SA Sandesara PB Senf SM | 2012 | FASEB J2012，26，： | 1 |
| 6 | p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle显示文摘 | Senf SM Sandesara PB Reed SA | 2011 | Am J Physiol Cell Physiol2011，300，6： | 1 |
| 7 | Decreased platelet number and function and increased fibrinolysis cintrbute to postoperative bleeding in cardiopulmonary bypass patients显示文摘 | Holloway Ds Surnmaria L Sandesara J | 1988 | Thromb Haemost1988，59，： | 1 |
| 8 | A randomized,placebo-controlled trial of omega-3 fatty acids for inhibition of supraventricular arrhythmias after cardiac surgery:The FISH Trial显示文摘 | SANDESARA C M CHUNG M K VAN WAGONER D R | 2012 | J Am Heart Assoc2012，1，00： | 1 |
| 9 | Quantification of cytomegalovirus (CMV) viral load by hybrid capture assay allows for early detection of CMV disease in lung transplant recipients显示文摘 | Bhorade SM Sandesara C Garrity ED | 2001 | J Heart Lung Transplant2001，20，9： | 1 |
| 10 | Active muscle regeneration following eccentric contractioninduced injury is similar between healthy young and older adults显示文摘 | Buford TW Macneil RG Clough LG Dirain M Sandesara B Pahor M | | 0，，： | 1 |
| 11 | Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients显示文摘 | Summaria L Sandesara J | 1988 | Thromb Haemost1988，59，1： | 1 |
| 12 | Asymptomatic coronary artery disease in type II diabetes 显示文摘 | Baweja PS Sandesara PB Ashraf MJ | 2014 | Mo Med2014，111，1： | 1 |
| 13 | Two synthetic anti- bodies that recognize and neutralize distinct proteolytic forms of the Ebola virus envelope glycoprotein显示文摘 | Koellhoffer J F Chen G Sandesara R G | 2012 | Chembiochem2012，13，17： | 1 |
| 14 | Decreased platelet number and function and increased fibrinolysis contribute to postoper, ative bleeding in cardiopulmonary bypass patients 显示文摘 | Holloway DS Summaria L Sandesara L | 1988 | Thromb Haemost1988，59，1： | 1 |
| 15 | A randomized, Placebo-Controlled trial of omega-3 fatty acids for inhibition of supraventricular arrhythmias after cardiac surgery: the FISH trial 显示文摘 | Sandesara CM Chung MK Van Wagoner DR | 2012 | Journal of the American Heart Association2012，1，3： | 1 |
| 16 | A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial显示文摘 | Chirag M. Sandesara Mina K. Chung David R. Van Wagoner Thomas A. Barringer Keith Allen Hassan M. Ismail Bridget Zimmerman Brian Olshansky | 2012 | Journal of the American Heart Association2012，，： | 1 |
| 17 | Arandomized, placebo-controlled trial of omega-3 fattyacids for inhibition of supraventricular arrhythmias aftercardiac surgery: the FISH trial显示文摘 | Sandesara CM Chung MK Van Wagoner DR | 2012 | J Am Heart Assoc2012，1，00： | 1 |
| 18 | Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients 显示文摘 | Holloway DS Summaria L Sandesara J | 1988 | Thromb Haemost1988，2559，1： | 1 |
| 19 | Primary Prevention of Cardiovascular Disease显示文摘Cardiovascular disease(CVD)is the leading cause of death worldwide.This article focuses on current guidelines for the primary prevention of CVD and addresses management of key risk factors.Dietary modifi cation,weight loss,exercise,and tobacco use cessation are specifi c areas where focused efforts can successfully reduce CVD risk on both an individual and a societal level.Specifi c areas requiring management include dyslipidemia,hypertension,physical activity,diabetes,aspirin use,and alcohol intake.These preventive efforts have major public health implications.As the global population continues to grow,health care expenditures will also rise,with the potential to eventually overwhelm the health care system.Therefore it is imperative to apply our collective efforts on CVD prevention to improve the cardiovascular health of individuals,communities,and nations. | Danny J.Eapen William M.Schultz Robert E.Heinl Nima Ghasemzadeh Tina Varghese Diana E.Kurian Christina E.Mathai Pratik Sandesara Bryan R.Kindya Marc P.Allard-Ratick Neal K.Bhatia Ijeoma Isiadinso Laurence Sperling | 2016 | Cardiovascular Innovations and Applications2016，，B09： | 1 |
| 20 | Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy显示文摘 | Reed S A Sandesara P B Senf S M Judge A R | 2012 | FASEB J2012，26，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员